Experimental knockdown of GCN2 in tumor cells has been shown to impair tumor progression and reduce angiogenesis in vivo, underscoring the dependence of tumor survival in nutrient-deprived microenvironments on GCN2–ATF4-mediated metabolic adaptation [95]. Here, EIF2AK4 is linked to neoplasm.